Related Experiment Video

Updated: May 15, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Some implications of receptor kinase signaling pathway for development of multitargeted kinase inhibitors

Petar M Mitrasinovic1

  • 1Department of Material Science and Chemistry, Faculty of Systems Engineering, Wakayama University, 930 Sakaedani, Wakayama, 640-8510 Japan. petar.mitrasinovic@yahoo.com

Current Radiopharmaceuticals
|January 3, 2013
PubMed

Insights

This study explores using epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitors for molecular imaging in tumors. It aims to reconcile drug targeting with tumor biochemistry for better PET and SPECT imaging agents.

Area of Science:

  • Oncology
  • Molecular Imaging
  • Radiopharmaceuticals

Background:

  • Epidermal growth factor receptors (EGFRs), part of the ErbB family of receptor tyrosine kinases (TKs), play a crucial role in tumor malignant progression.
  • The EGFR signaling pathway's involvement in various cancers has spurred interest in using EGFR-TK inhibitors for molecular imaging.

Purpose of the Study:

  • To reconcile the use of EGFR-TK inhibitors as imaging probes with the complex tumor biochemistry influencing radiopharmaceutical efficacy.
  • To guide the selection of appropriate radiolabeled agents for PET and SPECT imaging.
  • To support the development of next-generation multi-targeted kinase inhibitors.

Main Methods:

  • Review of the role of EGFR signaling in cancer.
  • Analysis of the principles of molecular imaging using PET and SPECT tracers.
  • Consideration of tumor-specific factors influencing tracer uptake and retention.
  • Discussion on reconciling kinase-level monitoring with tumor biochemistry.

Main Results:

  • EGFR-TK inhibitors offer a means for noninvasive monitoring of EGFR activity and drug occupancy.
  • Oncologic imaging tracers are influenced by tumor metabolism, proliferation, angiogenesis, hypoxia, apoptosis, and biomarkers.
  • A significant challenge lies in achieving routine drug selectivity for specific protein kinases.

Conclusions:

  • Reconciling EGFR-TK inhibitor imaging with tumor biochemistry is vital for developing effective PET and SPECT agents.
  • Future radiopharmaceuticals should consider both kinase inhibition and tumor-specific characteristics.
  • Advancing multi-targeted kinase inhibitors requires a holistic approach to molecular imaging agent design.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...